Conference Session Tracks

This track focuses on the latest breakthroughs in medicinal chemistry, emphasizing innovative approaches to drug design and development. Participants will explore novel bioactive molecules and their potential therapeutic applications.

SDG 3 SDG 4

This session will delve into the critical analysis of structure-activity relationships (SAR) that guide the optimization of drug candidates. Researchers will present case studies demonstrating how SAR informs medicinal synthesis and enhances pharmacological efficacy.

SDG 3 SDG 9

This track examines the intricate molecular interactions between drug candidates and their therapeutic targets. Discussions will highlight the significance of target validation in the context of drug discovery and development.

SDG 3 SDG 9

This session will showcase cutting-edge techniques in combinatorial chemistry that facilitate the rapid synthesis of diverse compound libraries. Participants will discuss strategies for identifying lead compounds with optimal biological activity.

SDG 3 SDG 9

This track emphasizes the intersection of chemical biology and medicinal applications, focusing on how chemical tools can elucidate biological processes. Presentations will cover the development of small molecules as probes for therapeutic targets.

SDG 3 SDG 9

This session will explore the methodologies for ligand optimization in the context of drug design. Researchers will present their findings on enhancing binding affinity and selectivity through rational design and empirical approaches.

SDG 3 SDG 9

This track focuses on the importance of ADMET (absorption, distribution, metabolism, excretion, and toxicity) studies in the pharmaceutical development process. Participants will discuss strategies for predicting and improving the pharmacokinetic profiles of drug candidates.

SDG 3 SDG 9

This session will highlight the role of molecular docking and computational chemistry in predicting drug-target interactions. Researchers will share insights into the use of computational tools for enhancing drug discovery workflows.

SDG 3 SDG 9

This track will explore the mechanisms of enzyme inhibition as a therapeutic strategy in drug development. Presentations will cover recent discoveries in enzyme inhibitors and their implications for treating various diseases.

SDG 3 SDG 9

This session will address the pharmacokinetic principles that govern drug absorption, distribution, metabolism, and excretion. Participants will discuss the impact of these factors on drug efficacy and safety profiles.

SDG 3 SDG 9

This track will focus on the latest trends and innovations in pharmaceutical sciences, including novel drug delivery systems and formulation strategies. Researchers will present their work on enhancing therapeutic outcomes through advanced pharmaceutical technologies.

SDG 3 SDG 9